Northwest Biotherapeutics (NWBO) Preferred Stock Liabilities (2012 - 2026)
Northwest Biotherapeutics' Preferred Stock Liabilities came in at $10.4 million for Q2 2026, down 24.4% from $13.75 million a year earlier and down 16.7% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Preferred Stock Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Northwest Biotherapeutics' Preferred Stock Liabilities was $12.71 million, down 18.0% from FY2024.
- Preferred Stock Liabilities has declined in each of the last three years, with a three-year compound annual growth rate of -18.0% (FY2022 to FY2025).
- Going back by year, Preferred Stock Liabilities was $15.51 million in FY2024 (-17.2%), $18.72 million in FY2023 (-18.8%) and $23.06 million in FY2022.
- The Q2 2026 figure represents the lowest quarterly Preferred Stock Liabilities since Q4 2013.
- Year-over-year, Preferred Stock Liabilities has declined for 11 consecutive quarters, with an average decline of 23.2% over the last eight quarters.
- The fastest year-over-year change in Preferred Stock Liabilities over five years came in Q3 2023 (growth of 101.3%), and the weakest in Q3 2024 (a decline of 42.6%).
- Business Quant data shows NWBO's Preferred Stock Liabilities at $12.48 million (Q1 2026), $12.71 million (Q4 2025) and $13.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | 10.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.40 Mn |
| Mar 31, 2026 | 12.48 Mn |
| Dec 31, 2025 | 12.71 Mn |
| Sep 30, 2025 | 13.40 Mn |
| Jun 30, 2025 | 13.75 Mn |
| Mar 31, 2025 | 14.64 Mn |
| Dec 31, 2024 | 15.51 Mn |
| Sep 30, 2024 | 15.88 Mn |
| Jun 30, 2024 | 18.75 Mn |
| Mar 31, 2024 | 19.81 Mn |
| Dec 31, 2023 | 18.72 Mn |
| Sep 30, 2023 | 27.67 Mn |
| Jun 30, 2023 | 25.39 Mn |
| Mar 31, 2023 | 23.75 Mn |
| Dec 31, 2022 | 23.06 Mn |
| Sep 30, 2022 | 13.75 Mn |
| Jun 30, 2018 | 20.51 Mn |
| Mar 31, 2018 | 17.80 Mn |
| Dec 31, 2017 | 20.04 Mn |
| Dec 31, 2013 | 8.91 Mn |
API Access
Northwest Biotherapeutics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();